Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
While compounded formulations are not FDA-approved as finished products, they use FDA-approved active pharmaceutical ingredients and follow established pharmaceutical compounding practices
L.TurnerA
Gerstein HC, et al
Like tirzepatide, retatrutide activates both GLP-1 and GIP receptors, producing the same appetite suppression, insulin enhancement, and fat metabolism improvements
GIP receptor agonism is hypothesised, based on preclinical and early clinical data, to complement GLP-1 effects on insulin secretion and may influence adipose tissue metabolism, though the precise contribution in humans remains an area of active investigation
Adjustments in this phase are typically minor
US$ 28.09
US$ 29.78
US$ 27.29
